Ticker
EOLSCompany Name
EVOLUS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -48.24M | -17.36% | $ 277.94M |
3/31/2025 | $ -28.9M | -10.49% | $ 275.46M |
12/31/2024 | $ -22.82M | -8.57% | $ 266.27M |
9/30/2024 | $ -25.82M | -10.4% | $ 248.33M |
6/30/2024 | $ -20.15M | -8.49% | $ 237.26M |
3/31/2024 | $ -25.95M | -11.81% | $ 219.7M |
12/31/2023 | $ -35.63M | -17.63% | $ 202.09M |
9/30/2023 | $ -46.25M | -25.04% | $ 184.73M |
6/30/2023 | $ -62.74M | -37.21% | $ 168.61M |
3/31/2023 | $ -70.49M | -45.06% | $ 156.43M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for EVOLUS INC is calculated as follows: FCF [ $ -75.51M ] / Revenues [ $ 55.41M ]
(=) FCF % [ -136.27% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |